Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Haas

Showing results (441-450 of 542) with videos related to

Pageof 55
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 7, 2002
Are Pfiesteria species toxicogenic? Evidence against production of ichthyotoxins by Pfiesteria shumwayaeJ P Berry, K S Reece, K S Rein, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|December 2, 2010
Use of biological knowledge to inform the analysis of gene-gene interactions involved in modulating virologic failure with efavirenz-containing treatment regimens in ART-naïve ACTG clinical trials participantsBenjamin J Grady, Eric S Torstenson, Paul J McLaren, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|June 23, 2011
[New recommendations for contact tracing in tuberculosis]R Diel, G Loytved, A Nienhaus, et al.
The Journal of Infectious Diseases|May 5, 2022
Pharmacogenetics of Dolutegravir Plasma Exposure Among Southern Africans With Human Immunodeficiency VirusZinhle Cindi, Aida N Kawuma, Gary Maartens, et al.
Sports Medicine - Open|May 31, 2016
Prevalence and Impact of Anemia on Basic Trainees in the US Air ForceKathryn E Myhre, Bryant J Webber, Thomas L Cropper, et al.
Open Forum Infectious Diseases|April 18, 2015
Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group ProtocolsCarrie B Moore, Anurag Verma, Sarah Pendergrass, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|December 31, 2023
Lymphocyte Count Derived Polygenic Score and Interindividual Variability in CD4 T-cell Recovery in Response to Antiretroviral TherapyKathleen M Cardone, Scott Dudek, Karl Keat, et al.
HIV Clinical Trials|December 17, 2013
Addition of nitazoxanide to PEG-IFN and ribavirin to improve HCV treatment response in HIV-1 and HCV genotype 1 coinfected persons naïve to HCV therapy: results of the ACTG A5269 trialValerianna K Amorosa, Anne Luetkemeyer, Minhee Kang, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2014
Phase I safety, pharmacokinetics, and pharmacogenetics study of the antituberculosis drug PA-824 with concomitant lopinavir-ritonavir, efavirenz, or rifampinKelly E Dooley, Anne F Luetkemeyer, Jeong-Gun Park, et al.
Health Psychology Review|March 3, 2025
A scoping review of placebo and nocebo responses and effects: insights for clinical trials and practiceArianna Bagnis, Stefanie H Meeuwis, Julia W Haas, et al.
Pageof 55

Showing results (441-450 of 542) with videos related to

Sort By:
Pageof 55
Proceedings of the National Academy of Sciences of the United States of America|August 7, 2002
Are Pfiesteria species toxicogenic? Evidence against production of ichthyotoxins by Pfiesteria shumwayaeJ P Berry, K S Reece, K S Rein, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|December 2, 2010
Use of biological knowledge to inform the analysis of gene-gene interactions involved in modulating virologic failure with efavirenz-containing treatment regimens in ART-naïve ACTG clinical trials participantsBenjamin J Grady, Eric S Torstenson, Paul J McLaren, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|June 23, 2011
[New recommendations for contact tracing in tuberculosis]R Diel, G Loytved, A Nienhaus, et al.
The Journal of Infectious Diseases|May 5, 2022
Pharmacogenetics of Dolutegravir Plasma Exposure Among Southern Africans With Human Immunodeficiency VirusZinhle Cindi, Aida N Kawuma, Gary Maartens, et al.
Sports Medicine - Open|May 31, 2016
Prevalence and Impact of Anemia on Basic Trainees in the US Air ForceKathryn E Myhre, Bryant J Webber, Thomas L Cropper, et al.
Open Forum Infectious Diseases|April 18, 2015
Phenome-wide Association Study Relating Pretreatment Laboratory Parameters With Human Genetic Variants in AIDS Clinical Trials Group ProtocolsCarrie B Moore, Anurag Verma, Sarah Pendergrass, et al.
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|December 31, 2023
Lymphocyte Count Derived Polygenic Score and Interindividual Variability in CD4 T-cell Recovery in Response to Antiretroviral TherapyKathleen M Cardone, Scott Dudek, Karl Keat, et al.
HIV Clinical Trials|December 17, 2013
Addition of nitazoxanide to PEG-IFN and ribavirin to improve HCV treatment response in HIV-1 and HCV genotype 1 coinfected persons naïve to HCV therapy: results of the ACTG A5269 trialValerianna K Amorosa, Anne Luetkemeyer, Minhee Kang, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2014
Phase I safety, pharmacokinetics, and pharmacogenetics study of the antituberculosis drug PA-824 with concomitant lopinavir-ritonavir, efavirenz, or rifampinKelly E Dooley, Anne F Luetkemeyer, Jeong-Gun Park, et al.
Health Psychology Review|March 3, 2025
A scoping review of placebo and nocebo responses and effects: insights for clinical trials and practiceArianna Bagnis, Stefanie H Meeuwis, Julia W Haas, et al.
Pageof 55